BSECompany Update10 Oct 2026 · 10 Oct 2026, 11:38 am

Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30-09-2026

Kwality Pharmaceuticals Ltd · 539997

✦ AI Summary

Kwality Pharmaceuticals Ltd has submitted a certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, confirming the dematerialization of securities up to September 30, 2026.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Kwality Pharmaceuticals Ltd - 539997 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Attachments (1)

📄

43ee4dc1-3263-4571-80f9-3f9ed23adc40.pdf

pdf

Download →
View document text
CIN No. L24232PB1983PLC005426 GST No. 03AAACK6458M1ZB Phone : 91-8558820862 (Accounts) 8 D.L. No. 1800-0SP, 1804-B I.E. Code No. 1293001210 : 91-8558820863 (Admin.) : 91-9915743720 (Exports) K1VALITY PHARMACEUTICALS LIMITED M.D. Mobile: 91-9814071215, 9814052314 E-mail : export@kwalitypharma.com Regd. Office: Village Nag KaIan, Majitha Road, Amritsar - 143 601 (INDIA) ramesh@kwalitypharma.com Date: October 10, 2026 The Department of Corporate services BSE Limited Phiroze Jeejeebhoy Towers, 25th Floor, Dalai Street, Mumbai-400001 Scrip Code: 539997 Subject: Certificate under Regulation 74(5) of SEB1 (Depositories and Participants.' Regulations. 2018 for the Quarter Ended September 30. 2026 Dear Sir/Madam, With reference to the captioned subject, please find enclosed herewith confirmation certificate issued in accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026 as received from Bigshare Services Private Limited, the Registrar and Share Transfer Agent of the Company. Please take the same on records. Yours Faithfully For Kwality Pharmaceuti P' 11- Gurpreet Kaur Company Secretary & Compliance Ref No. BSS/74(5) Date: 09/10/2026 KWALITY PHARMACEUTICALS LTD VILLAGE NAGKALAN MAJITHA ROAD AMRITSAR PUNJAB AMRITSAR- 143601 Dear Sir/Madam, Sub: Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2026 Ref: NSDL/CIR/II/5/2019 dated 25th January 2019 DSL/OPS/RTA/POLICY/2019/14 dated 25th January 2019. SEBI vide its letter ref no. MRD/DOP2/DSA2/OW/2019/2498/1 dated 24/01/2019 In reference to the above – captioned regulation we hereby confirm that the securities received from the depository Participants for dematerialization up to 30th September 2026 were confirmed (accepted/rejected) to the depositories by us and that securities comprised in the said certificates have been listed on the stock exchange where the earlier issued securities are listed. We hereby confirm that the security certificates received for dematerialization have been mutilated & cancelled after due verification by the depository Participant and the name of the depositories have been substituted in register of members as registered owner within 15 days of receipt of certificate of securities. We request you to kindly take note of the above in your records. This is for your information. Thanking You, Yours faithfully, For Bigshare Services Pvt. Ltd., Sandeep More Authorised Signatory